Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector?

Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical development, and safety testing services. It is valued at a market cap of $7.6 billion. Companies worth $2 billion or more are typically classified as “mid-cap stocks,” and CRL fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the diagnostics & research industry. By partnering with global research institution ...